| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |